Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D8ZNW0
|
|||
| Drug Name |
MDR-102
|
|||
| Drug Type |
Cell therapy
|
|||
| Indication | Kidney transplant rejection [ICD-11: NE84; ICD-9: 996.81] | Phase 2 | [1] | |
| Company |
Medeor Therapeutics
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03605654) Cellular Immunotherapy in Recipients of Human Leukocyte Antigen (HLA)-Mismatched, Living Donor Kidney Transplants. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.